Regarded as the principal annual event for statisticians in the pharmaceutical and healthcare industry in Europe, the 2016 PSI conference is taking place at The Pullman Hotel, Berlin, between 22 to 25th May 2016. It will be the 39th consecutive annual event.
Sessions will include
an update on estimands, subgroups, dose exposure modelling, decision criteria,
use of biomarkers in translational activities, personalised medicine and many
more with speakers from industry, academia and regulatory agencies.
You can be involved in the conference; we’re accepting abstracts for contributed presentations and posters. Note the following deadlines:
Oral
Abstract: 30th November 2015
Poster
Abstract: 29th February
2016
We
welcome abstracts on any subject but would be particularly interested in the
following:
- Bayesian
topics within early or late phase
- Challenges
in small patient populations (including rare diseases and paediatrics)
- Examples
of clinical trial data transparency
- The use
of decision criteria in early phase development
- Case
studies involving dose exposure / dose response modelling
- Topics
relating to medical device trials
- Novel
designs
- Examples
using Risk Based Monitoring methods
- Case
studies involving translational research (biomarkers, genomics etc)
If you
are a career young statistician (approximately less than 5 years working in the
pharmaceutical industry) then there will be a dedicated contributed session for
you. This is a great opportunity to gain experience in presenting in a friendly
environment and to network with peers at other companies.
In
order to submit an abstract, please go to http://www.psiweb.org/ and download a form, which must be completed and sent to [log in to unmask]. Successful
applicants will be notified within one week following the deadline.
